Global expansion BioDot is expanding its footprint with a new Irvine, California headquarters, signaling potential for regional sales growth, local service contracts, and on-site demonstrations to accelerate cross-border opportunities in North America.

Diagnostics leadership With over 3 billion diagnostic tests produced annually and expertise in Lateral Flow, PCR, and immunoassays, there are substantial upsell opportunities for new dispensing systems, assay kits, and consumables across clinical diagnostics and infectious disease testing.

Strategic partnerships Recent and ongoing collaborations, such as the Empire Genomics partnership for FISH probe panels, indicate a channel-ready path for co-developed solutions, enabling joint go-to-market efforts and expanded product lines tailored to cytogenetics and molecular diagnostics.

High precision demand BioDot’s specialization in picoliter to microliter liquid handling supports demanding applications in microfluidics, lab-on-a-chip devices, and biosensors, presenting opportunities to upsell advanced dispensing hardware, automation integration, and validation services to drug development and life sciences customers.

Government and global reach As a global leader with batch and in-line manufacturing, BioDot serves diverse markets across the US, UK, Europe, and China, creating cross-regional sales opportunities for standardized systems, service agreements, and scalable workflows that meet regulatory and quality standards.